{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T15:12:05Z","timestamp":1719846725716},"reference-count":40,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003323","name":"ANRS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ANRS HIV Vaccine Network"},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.vaccine.2014.07.094","type":"journal-article","created":{"date-parts":[[2014,8,13]],"date-time":"2014-08-13T04:34:02Z","timestamp":1407904442000},"page":"5577-5584","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Natural killer cell responses to dendritic cells infected by the ANRS HIV-1 vaccine candidate, MVA HIV"],"prefix":"10.1016","volume":"32","author":[{"given":"Jean-Saville","family":"Cummings","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uriel Y.","family":"Moreno-Nieves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrien","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Yarbrough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celine","family":"Didier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"L\u00e9vy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7oise","family":"Barr\u00e9-Sinoussi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Scott-Algara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.07.094_bib0005","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nature10624","article-title":"Natural killer cells act as rheostats modulating antiviral T cells","volume":"481","author":"Waggoner","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0010","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1084\/jem.20091193","article-title":"Innate immunity defines the capacity of antiviral T cells to limit persistent infection","volume":"207","author":"Andrews","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0015","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1073\/pnas.1118834109","article-title":"Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity","volume":"109","author":"Lang","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0020","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng934","article-title":"Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS","volume":"31","author":"Martin","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0025","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/ng2035","article-title":"Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1","volume":"39","author":"Martin","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0030","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.micinf.2012.05.001","article-title":"Evasion from NK cell-mediated immune responses by HIV-1","volume":"14","author":"Jost","year":"2012","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0035","doi-asserted-by":"publisher","first-page":"5663","DOI":"10.4049\/jimmunol.171.11.5663","article-title":"Cutting edge: increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users","volume":"171","author":"Scott-Algara","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0040","doi-asserted-by":"publisher","first-page":"4296","DOI":"10.1182\/blood-2006-08-040238","article-title":"Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals","volume":"109","author":"Ravet","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0045","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/nri956","article-title":"Natural killer cells and dendritic cells: rendezvous in abused tissues","volume":"2","author":"Moretta","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0050","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1182\/blood-2005-03-1154","article-title":"Natural-killer cells and dendritic cells: \u201cl\u2019union fait la force\u201d","volume":"106","author":"Walzer","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0055","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/978-1-4614-0106-3_17","article-title":"NK\/DC crosstalk in anti-viral response","volume":"946","author":"Marcenaro","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0060","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.it.2011.02.003","article-title":"Mutiny or scrutiny: NK cell modulation of DC function in HIV-1 infection","volume":"32","author":"Alter","year":"2011","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0065","doi-asserted-by":"publisher","first-page":"5957","DOI":"10.4049\/jimmunol.172.10.5957","article-title":"IL-4 confers NK stimulatory capacity to murine dendritic cells: a signaling pathway involving KARAP\/DAP12-triggering receptor expressed on myeloid cell 2 molecules","volume":"172","author":"Terme","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0070","first-page":"157","article-title":"Dendritic cell-NK cell cross-talk: regulation and physiopathology","volume":"298","author":"Zitvogel","year":"2006","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0075","first-page":"17","article-title":"Dendritic cells (DC) promote natural killer (NK) cell functions: dynamics of the human DC\/NK cell cross talk","volume":"13","author":"Fernandez","year":"2002","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0080","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.4049\/jimmunol.1000844","article-title":"NK cells as effectors of acquired immune responses: effector CD4+ T cell-dependent activation of NK cells following vaccination","volume":"185","author":"Horowitz","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0085","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1172\/JCI22797","article-title":"T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus","volume":"114","author":"He","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0090","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1055\/s-0028-1108143","article-title":"MVA vaccination against smallpox: clinical tests with an attenuated live vaccinia virus strain (MVA)","volume":"99","author":"Stickl","year":"1974","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0095","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.copbio.2004.09.001","article-title":"Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential","volume":"15","author":"Drexler","year":"2004","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0100","doi-asserted-by":"publisher","first-page":"5314","DOI":"10.1128\/JVI.02329-09","article-title":"Preclinical studies of a modified vaccinia virus Ankara-based HIV candidate vaccine: antigen presentation and antiviral effect","volume":"84","author":"Brandler","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0105","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jim.2004.08.008","article-title":"CD107a as a functional marker for the identification of natural killer cell activity","volume":"294","author":"Alter","year":"2004","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0110","doi-asserted-by":"publisher","first-page":"8469","DOI":"10.1128\/JVI.02749-05","article-title":"Differences and similarities in viral life cycle progression and host cell physiology after infection of human dendritic cells with modified vaccinia virus Ankara and vaccinia virus","volume":"80","author":"Chahroudi","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0115","doi-asserted-by":"publisher","first-page":"7022","DOI":"10.1128\/JVI.02654-06","article-title":"Direct comparison of antigen production and induction of apoptosis by canarypox virus- and modified vaccinia virus ankara-human immunodeficiency virus vaccine vectors","volume":"81","author":"Zhang","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0120","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.4049\/jimmunol.169.8.4279","article-title":"Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection","volume":"169","author":"Nguyen","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0125","doi-asserted-by":"publisher","first-page":"16606","DOI":"10.1073\/pnas.0407522101","article-title":"Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs","volume":"101","author":"Ferlazzo","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0130","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","article-title":"Human natural killer cells","volume":"112","author":"Caligiuri","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0135","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201344149","article-title":"NK cells are primed by ANRS MVAHIV-infected DCs, via a mechanism involving NKG2D and membrane-bound IL-15, to efficiently control HIV-1 infection in CD4+ T cells","author":"Moreno-Nieves","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0140","doi-asserted-by":"publisher","first-page":"4496","DOI":"10.1128\/JVI.05788-11","article-title":"The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR","volume":"86","author":"Matusali","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0145","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.virol.2010.05.014","article-title":"MHC class I chain-related protein A shedding in chronic HIV-1 infection is associated with profound NK cell dysfunction","volume":"406","author":"Nolting","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0150","doi-asserted-by":"publisher","first-page":"12254","DOI":"10.1128\/JVI.05835-11","article-title":"Modulation of NKG2D-mediated cytotoxic functions of natural killer cells by viral protein R from HIV-1 primary isolates","volume":"85","author":"Pham","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0155","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1099\/vir.0.82125-0","article-title":"Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity","volume":"88","author":"Cerboni","year":"2007","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0160","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.tim.2008.09.002","article-title":"KIR\u2013HLA intercourse in HIV disease","volume":"16","author":"Carrington","year":"2008","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0165","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1084\/jem.20070695","article-title":"Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR\/HLA subtypes","volume":"204","author":"Alter","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0170","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/infdis\/jiq075","article-title":"Impact of a functional KIR2DS4 allele on heterosexual HIV-1 transmission among discordant Zambian couples","volume":"203","author":"Merino","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0175","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1371\/journal.ppat.0040030","article-title":"A role for NKG2D in NK cell-mediated resistance to poxvirus disease","volume":"4","author":"Fang","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0180","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1126\/science.1215621","article-title":"Tuning of natural killer cell reactivity by NKp46 and Helios calibrates T cell responses","volume":"335","author":"Narni-Mancinelli","year":"2012","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.vaccine.2014.07.094_bib0185","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.immuni.2013.12.011","article-title":"Costimulatory molecule DNAM-1 is essential for optimal differentiation of memory natural killer cells during mouse cytomegalovirus infection","volume":"40","author":"Nabekura","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0190","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.0105-2896.2010.00891.x","article-title":"Memory-like responses of natural killer cells","volume":"235","author":"Cooper","year":"2010","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0195","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/j.0105-2896.2010.00906.x","article-title":"Adaptive immune responses mediated by natural killer cells","volume":"235","author":"Paust","year":"2010","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2014.07.094_bib0200","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature07665","article-title":"Adaptive immune features of natural killer cells","volume":"457","author":"Sun","year":"2009","journal-title":"Nature"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14010767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14010767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T17:26:22Z","timestamp":1565717182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14010767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":40,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0264410X14010767"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.07.094","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural killer cell responses to dendritic cells infected by the ANRS HIV-1 vaccine candidate, MVAHIV","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.07.094","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}